Variable | Adj. HRa | 95% CI | P value | |
---|---|---|---|---|
Treatment | ||||
Yes (reference group) | - | - | - | - |
No | 2.66 | 2.49 | 2.84 | <0.001* |
Sex | ||||
Female (reference group) | - | - | - | - |
Male | 0.92 | 0.88 | 0.96 | <0.001* |
Age at diagnosis, years | ||||
≤44( (reference group) | - | - | - | - |
45–54 | 0.86 | 0.80 | 0.93 | <0.001* |
55–64 | 0.89 | 0.82 | 0.96 | 0.002* |
65–74 | 1.04 | 0.96 | 1.12 | 0.366 |
≥75 | 1.75 | 1.63 | 1.88 | <0.001* |
Urbanization level of residence location | ||||
Level 1 (highest; reference group) | - | - | - | - |
Level 2 | 0.97 | 0.92 | 1.02 | 0.233 |
Level 3 | 1.06 | 1.00 | 1.13 | 0.052 |
Level 4 | 1.05 | 0.99 | 1.12 | 0.112 |
Level 5 | 1.05 | 0.95 | 1.17 | 0.333 |
Level 6 | 1.05 | 0.96 | 1.14 | 0.306 |
Level 7 (lowest) | 1.17 | 1.07 | 1.28 | 0.001* |
Aboriginal status | ||||
No (reference group) | - | - | - | - |
Yes | 0.89 | 0.71 | 1.12 | 0.328 |
Insured monthly salary, NTD | ||||
≤17,280 (reference group) | - | - | - | - |
Insured dependent | 0.97 | 0.90 | 1.05 | 0.455 |
17,281–22,800 | 1.00 | 0.95 | 1.05 | 0.908 |
≥22,801 | 0.80 | 0.75 | 0.85 | <0.001* |
Low-income household status | ||||
No (reference group) | - | - | - | - |
Yes | 1.53 | 1.32 | 1.79 | <0.001* |
Other catastrophic illnesses or injuries | ||||
No (reference group) | - | - | - | - |
Yes | 1.83 | 1.68 | 2.00 | <0.001* |
Cancer stage | ||||
Stage 0 (reference group) | - | - | - | - |
Stage I | 1.59 | 1.30 | 1.95 | <0.001* |
Stage II | 2.63 | 2.16 | 3.21 | <0.001* |
Stage III | 3.84 | 3.16 | 4.68 | <0.001* |
Stage IV | 19.38 | 15.96 | 23.54 | <0.001* |